Rob Stein

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 25 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Pages

5:06pm

Tue October 14, 2014
Shots - Health News

Embryonic Stem Cells Restore Vision In Preliminary Human Test

Originally published on Fri October 17, 2014 9:39 am

Isabella Beukes, of Santa Rosa, Calif., has been legally blind for more than 40 years. An experimental treatment derived from embryonic stem cells seems to have enabled her now to see not just color but also some shapes.
Tim Hussin for NPR

Scientists are reporting the first strong evidence that human embryonic stem cells may be helping patients.

The cells appear to have improved the vision in more than half of the 18 patients who had become legally blind because of two progressive, currently incurable eye diseases.

The researchers stress that the findings must be considered preliminary because the number of patients treated was relatively small and they have only been followed for an average of less than two years.

Read more
Tags: 

10:18am

Thu October 9, 2014
Shots - Health News

Scientists Coax Human Embryonic Stem Cells Into Making Insulin

Originally published on Thu October 9, 2014 4:28 pm

Insulin is produced by the green cells that are in clusters about the same size as the islets in the human pancreas. The red cells are producing another metabolic hormone, glucagon, that prevents low blood sugar.
Harvard University

A team of Harvard scientists said Thursday that they had finally found a way to turn human embryonic stem cells into cells that produce insulin. The long-sought advance could eventually lead to new ways to help millions of people with diabetes.

Right now, many people with diabetes have to regularly check the level of sugar in their blood and inject themselves with insulin to keep the sugar in their blood in check. It's an imperfect treatment.

Read more

2:24pm

Mon September 8, 2014
Shots - Health News

Researcher Urges Wider Genetic Screening For Breast Cancer

Originally published on Tue September 9, 2014 10:43 am

Lisa Schlager of Chevy Chase, Md., demonstrates outside of the Supreme Court as arguments were made in a case seeking to determine whether the BRCA breast cancer genes can be patented. The court ruled in 2013 that individual genes can't be patented.
Tom Williams CQ Roll Call/Getty

A prominent scientist has started a big new debate about breast cancer. Geneticist Mary-Claire King of the University of Washington, who identified the first breast cancer gene, is recommending that all women get tested for genetic mutations that can cause breast cancer.

Read more

11:38am

Fri August 29, 2014
Shots - Health News

Experimental Drug Saves Monkeys Stricken With Ebola

Originally published on Fri August 29, 2014 6:40 pm

A Public Health Agency of Canada worker seen inside the National Microbiology Laboratory's Level 4 lab in Winnipeg.
Public Health Agency of Canada/Nature

Scientists are reporting strong evidence that the experimental Ebola drug ZMapp may be effective for treating victims of the devastating disease.

A study involving 18 rhesus macaque monkeys, published Friday in the journal Nature, found that the drug saved 100 percent of the animals even if they didn't receive the drug until five days after they had been infected. The study is the first to test ZMapp in a primate, which is considered a good model for how a drug might work in humans.

Read more

2:56am

Fri August 22, 2014
World

The Dread Factor: Why Ebola And 'Contagion' Scare Us So Much

Originally published on Fri August 22, 2014 8:16 am

Jude Law prepares for the looming pandemic in the 2011 movie Contagion. There are huge differences between viruses in movies and Ebola in real life.
Warner Bros/The Kobal Collection

The Ebola outbreak has set off an alarm around the world. Public health leaders say the intense concern is appropriate, given the unprecedented size of the outbreak and the deadliness of the virus.

But experts say the outbreak has also produced a lot of unfounded fears. Even just the word Ebola is kind of terrifying.

Why? Well, Hollywood has a lot to do with it.

Read more

Pages